Back to results: osu endocrinology / arizona, US
Posted on: 07 Mar 2024
Job Location: Morenci, US
Job Description:
Job Title: Sales Specialist
Company Type: Small Biotech
Territory: Lansing, Grand Rapids, Saginaw, Traverse City, & the Upper Peninsula (note: Detroit is NOT in this territory)
Therapy Area: Rare Disease / Endocrinology
Why This Role:
Role Description:
Qualifications Include:
EPM Scientific is the only search firm dedicated to offering bench to bedside recruitment services with niche experts across every vertical of the development, approval, and launch cycle.
Our Commercial Expertise
Our commercial business unit has been a critical part of staffing launch teams for many of the most exciting developments in life sciences over the past 8 years. From building PD1 Inhibitor teams in 2016, to staffing the commercial experts as part of multi-billion-dollar integrations in 2018, through to recruiting national sales teams for leading global pharma companies as they launched cost-effective solutions to patients in biosimilars through 2022. We are now partnered with the most cutting-edge small biotech & large multi-national pharma companies focused on the future of medicine within Gene Therapy and Rare Diseases.
Throughout EPMs development we have continued to add niche verticals critical to our partners with the core expertise in pharmaceuticals, medical device, and outsourced services (CRO, CDMO). EPM Scientific serves the fastest growing large or small life sciences companies in the world and offers mid to executive level talent through a curated recruitment experience working with consultants who are deeply passionate about their space.
Exact compensation may vary based on skills, experience, and location. The salary range for this position is $140,000-150,000.
By clicking on "Continue", I give receptix consent to process my data and to send me email alerts, as detailed in receptix's Privacy Policy . I may withdraw my consent or unsubscribe at any time.
Similar jobs
Rare Disease Sales Specialist
Morenci, US
07 Mar 2024